Children requiring catheter-based interventions for complex congenital heart defects benefit from ICMR’s radiation-free imaging and superior soft-tissue visualisation. This approach minimises cumulative radiation exposure and enables precise, real-time guidance for delicate procedures.
Radiation-free precision for structural and congenital heart care
Interventional cardiac MRI (ICMR) offers a transformative interventional approach for cardiology. Unlike traditional imaging modalities, ICMR enables real-time, radiation-free visualisation of cardiac anatomy and function. This is especially critical for young patients, where minimising cumulative radiation exposure is essential.
MRI’s superior soft-tissue contrast allows for real-time visualisation of the cardiac muscle during diagnostics and intervention, making it ideal for congenital heart disease, catheter-based interventions, and repeat procedures.
New clinical opportunities
Paediatric patients with congenital heart disease
Patients with pulmonary hypertension or complex haemodynamics
Individuals with conditions like pulmonary hypertension or structural lung disease need accurate haemodynamic assessment.
ICMR combines invasive catheterisation with MRI flow analysis for precise pulmonary vascular resistance calculations—critical for surgical decision-making and operability assessment.
Patients undergoing electrophysiology or advanced cardiac interventions
Those requiring arrhythmia ablation, endomyocardial biopsy, or complex structural interventions benefit from ICMR’s real-time imaging and tissue characterisation. This improves procedural safety and efficacy compared to traditional x-ray-guided approaches.
ICMR is already being used to guide:
- MRI catheterisation for congenital heart defects
- stress testing in Fontan patients
- real-time phase contrast imaging for flow mapping
- MRI-guided ablation and biopsies
These applications demonstrate how ICMR can support safer, more effective interventions tailored to the unique needs of paediatric patients.
10% of all paediatric/adolescent haematologic cancers may be linked to medical-imaging radiation exposure. The strongest associations were observed within 6 months to 4 years post-exposure.1
'I felt 20 pounds lighter that day. I’m walking into the iMRI Suite and I don’t have to wear lead, because guess what? There’s no radiation. And you can see everything. That was another game‑changer for me.'
Built for clinical impact and institutional sustainability
The iMRI Suite aligns advanced image-guided intervention with existing procedural and reimbursement pathways (subject to local policy).
With cross-specialty utilisation and 24/7 imaging potential, it supports both patient outcomes and operational performance.
View economic framework- Smith-Bindman R, Alber SA, Kwan ML, et al. Medical imaging and pediatric and adolescent hematologic cancer risk. N Engl J Med. 2025;393(13):1269–1278.